Roger Briesewitz

2.6k total citations
26 papers, 1.8k citations indexed

About

Roger Briesewitz is a scholar working on Molecular Biology, Immunology and Allergy and Hematology. According to data from OpenAlex, Roger Briesewitz has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Immunology and Allergy and 6 papers in Hematology. Recurrent topics in Roger Briesewitz's work include Cell Adhesion Molecules Research (7 papers), Signaling Pathways in Disease (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Roger Briesewitz is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Signaling Pathways in Disease (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Roger Briesewitz collaborates with scholars based in United States, Germany and Austria. Roger Briesewitz's co-authors include Eugene E. Marcantonio, Andreas Kern, Michael A. Caligiuri, Ziqing Qian, Dehua Pei, Michael Epstein, Punit Upadhyaya, John H. Griffin, Joey Leung and Ilan Bank and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Roger Briesewitz

26 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Briesewitz United States 19 1.1k 394 386 376 221 26 1.8k
Jianghai Zhu United States 16 1.1k 1.0× 198 0.5× 1.1k 3.0× 376 1.0× 539 2.4× 19 2.5k
Bonnie F. Sloane United States 15 738 0.6× 712 1.8× 243 0.6× 144 0.4× 95 0.4× 17 1.4k
Alex O. Morla United States 13 1.1k 1.0× 427 1.1× 515 1.3× 127 0.3× 238 1.1× 13 1.9k
Lars S. Nielsen Denmark 19 435 0.4× 673 1.7× 216 0.6× 675 1.8× 172 0.8× 28 1.4k
Katharina Blatt Austria 26 1.8k 1.6× 141 0.4× 744 1.9× 1.0k 2.7× 407 1.8× 58 3.2k
Maurizio Di Liberto United States 17 1.1k 1.0× 155 0.4× 103 0.3× 225 0.6× 206 0.9× 49 1.8k
Edwin L. Madison United States 21 833 0.7× 610 1.5× 172 0.4× 491 1.3× 112 0.5× 34 1.6k
Annalisa Siri Italy 22 909 0.8× 496 1.3× 1.3k 3.4× 94 0.3× 290 1.3× 36 2.2k
Enrica Balza Italy 29 1.4k 1.2× 512 1.3× 1.1k 2.8× 101 0.3× 728 3.3× 56 3.1k
Mark B. Meads United States 12 771 0.7× 307 0.8× 103 0.3× 441 1.2× 307 1.4× 36 1.6k

Countries citing papers authored by Roger Briesewitz

Since Specialization
Citations

This map shows the geographic impact of Roger Briesewitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Briesewitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Briesewitz more than expected).

Fields of papers citing papers by Roger Briesewitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Briesewitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Briesewitz. The network helps show where Roger Briesewitz may publish in the future.

Co-authorship network of co-authors of Roger Briesewitz

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Briesewitz. A scholar is included among the top collaborators of Roger Briesewitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Briesewitz. Roger Briesewitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upadhyaya, Punit, et al.. (2015). Inhibition of Ras Signaling by Blocking Ras–Effector Interactions with Cyclic Peptides. Angewandte Chemie International Edition. 54(26). 7602–7606. 120 indexed citations
2.
Wú, Xiànghóng, Punit Upadhyaya, Miguel A. Villalona‐Calero, Roger Briesewitz, & Dehua Pei. (2012). Inhibition of Ras–effector interactions by cyclic peptides. MedChemComm. 4(2). 378–382. 54 indexed citations
3.
Qian, Ziqing, Tao Liu, Yuyu Liu, et al.. (2012). Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs. ACS Chemical Biology. 8(2). 423–431. 155 indexed citations
4.
Wú, Xiànghóng, Lisheng Wang, Yaohua Han, et al.. (2011). Creating Diverse Target-Binding Surfaces on FKBP12: Synthesis and Evaluation of a Rapamycin Analogue Library. ACS Combinatorial Science. 13(5). 486–495. 26 indexed citations
8.
Benson, Don M., Jianhua Yu, Brian Becknell, et al.. (2008). Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. Blood. 113(12). 2706–2714. 39 indexed citations
9.
Sellmyer, Mark A., Kryn Stankunas, Roger Briesewitz, Gerald R. Crabtree, & Thomas J. Wandless. (2007). Engineering small molecule specificity in nearly identical cellular environments. Bioorganic & Medicinal Chemistry Letters. 17(10). 2703–2705. 4 indexed citations
10.
Caligiuri, Michael A., Roger Briesewitz, Jianhua Yu, et al.. (2007). Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood. 110(3). 1022–1024. 119 indexed citations
11.
Griffin, John H., et al.. (2003). Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proceedings of the National Academy of Sciences. 100(13). 7830–7835. 151 indexed citations
12.
Braun, Patrick D., Katherine T. Barglow, Yun‐Ming Lin, et al.. (2003). A Bifunctional Molecule That Displays Context-Dependent Cellular Activity. Journal of the American Chemical Society. 125(25). 7575–7580. 39 indexed citations
13.
Vogel, Kurt W., Roger Briesewitz, Thomas J. Wandless, & Robert H. Crabtree. (2001). Calcineurin inhibitors and the generalization of the presenting protein strategy. Advances in protein chemistry. 56. 253–291. 9 indexed citations
14.
Briesewitz, Roger, Andreas Kern, Lubomir B. Smilenov, Frank David, & Eugene E. Marcantonio. (1996). The membrane-cytoplasm interface of integrin alpha subunits is critical for receptor latency.. Molecular Biology of the Cell. 7(10). 1499–1509. 14 indexed citations
15.
Dalton, Stephen, et al.. (1995). Cell adhesion to extracellular matrix regulates the life cycle of integrins.. Molecular Biology of the Cell. 6(12). 1781–1791. 65 indexed citations
16.
Briesewitz, Roger, Andreas Kern, & Eugene E. Marcantonio. (1995). Assembly and function of integrin receptors is dependent on opposing alpha and beta cytoplasmic domains.. Molecular Biology of the Cell. 6(8). 997–1010. 30 indexed citations
17.
Smilenov, Lubomir B., Roger Briesewitz, & Eugene E. Marcantonio. (1994). Integrin beta 1 cytoplasmic domain dominant negative effects revealed by lysophosphatidic acid treatment.. Molecular Biology of the Cell. 5(11). 1215–1223. 30 indexed citations
18.
Briesewitz, Roger, Andreas Kern, & Eugene E. Marcantonio. (1993). Ligand-dependent and -independent integrin focal contact localization: the role of the alpha chain cytoplasmic domain.. Molecular Biology of the Cell. 4(6). 593–604. 82 indexed citations
19.
Briesewitz, Roger, Michael Epstein, & Eugene E. Marcantonio. (1993). Expression of native and truncated forms of the human integrin alpha 1 subunit.. Journal of Biological Chemistry. 268(4). 2989–2996. 96 indexed citations
20.
Hopewell, Robert, Mark Oram, Roger Briesewitz, & L. Mark Fisher. (1990). DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance. Journal of Bacteriology. 172(6). 3481–3484. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026